Dr. Fawzi Aoudjit is a senior scientist at the CHU de Québec Research Centre and a professor at the department of microbiology-infectiology and immunology of the Laval University School of Medicine. His research program seeks to understand the mechanisms controlling T cell activity in tissues during inflammatory/autoimmune diseases and cancer, with a focus on the role of the adhesion molecules that bind to extracellular matrix, the integrins. T cells play an important role in the adaptive immune response, but are also critical to the development of inflammatory diseases, and could become malignant and lead to cancer. Recent work by Dr. Aoudjit’s group significantly contributed to understand the importance of extracellular matrix-binding integrins in the regulation of T cell activation and the development of immune response. Along these lines, Dr. Aoudjit and his team have shown that the collagen-binding integrin alpha2beta1 is an important pathway in Th17 cell activation and in the development of arthritis. These studies were highlighted in the news bulletin ‘Immune regulation news’. Dr. Aoudjit received several acknowledgements for his work among which, the New Investigator Award from the Canadian Institutes of Health Research, in 2004.

The current objectives aim to

  1. understand how collagen receptors such as integrins and discoïdin domain receptors interact to promote the survival and migration of T cell subsets in inflammatory tissues; two critical T cell functions necessary to the development of inflammation, as well as to mounting an anti-cancer immune response.
  2. determine the role of integrins in the development of lymphoblastic leukemia by investigating their implication in the tissue dissemination of leukemic T cells, and in their resistance to chemotherapy; two cancer features that limit the efficacy of anti-cancer treatments.

The implication of these receptors in the development of inflammatory diseases and cancer is being investigated in human T cell models, in preclinical models of autoimmune diseases, leukemia, and in models of anti-cancer immunity, as well as at the clinical level with the collaboration of clinicians.

In addition to advancing knowledge, these studies aim at the discovery of novel therapeutic targets and treatments for autoimmune diseases and cancer.

CHUL
2705, boulevard Laurier
T-1-49
Québec, Québec
Canada G1V 4G2
52 entries « 2 of 6 »

El Azreq MA, Arseneault C, Boisvert M, Page N, Allaeys I, Poubelle PE, Tessier PA, Aoudjit F

Cooperation between IL-7 Receptor and Integrin α2β1 (CD49b) Drives Th17-Mediated Bone Loss.

Journal Article

J Immunol, 195 (9), pp. 4198-209, 2015, ISSN: 0022-1767.

Abstract | Links:

Gamara J, Chouinard F, Davis L, Aoudjit F, Bourgoin SG

Regulators and Effectors of Arf GTPases in Neutrophils.

Journal Article

J Immunol Res, 2015 , pp. 235170, 2015, ISSN: 2314-7156.

Abstract | Links:

Naci D, Aoudjit F

Alpha2beta1 integrin promotes T cell survival and migration through the concomitant activation of ERK/Mcl-1 and p38 MAPK pathways.

Journal Article

Cell Signal, 26 (9), pp. 2008-15, 2014, ISSN: 0898-6568.

Abstract | Links:

Lauden L, Siewiera J, Boukouaci W, Ramgolam K, Mourah S, Lebbe C, Charron D, Aoudjit F, Jabrane-Ferrat N, Al-Daccak R

TGF-β-induced (TGFBI) protein in melanoma: a signature of high metastatic potential.

Journal Article

J Invest Dermatol, 134 (6), pp. 1675-1685, 2014, ISSN: 0022-202X.

Abstract | Links:

El Azreq MA, Aoudjit F

Collagen-binding integrins in the pathogenesis of rheumatoid arthritis

Journal Article

Austin J Clin Immunol, 1 (2), pp. 1006, 2014, ISSN: 2381-9138.

| Links:

El Azreq MA, Boisvert M, Cesaro A, Page N, Loubaki L, Allaeys I, Chakir J, Poubelle PE, Tessier PA, Aoudjit F

α2β1 integrin regulates Th17 cell activity and its neutralization decreases the severity of collagen-induced arthritis.

Journal Article

J Immunol, 191 (12), pp. 5941-50, 2013, ISSN: 0022-1767.

Abstract | Links:

Loubaki L, Hadj-Salem I, Fakhfakh R, Jacques E, Plante S, Boisvert M, Aoudjit F, Chakir J

Co-culture of human bronchial fibroblasts and CD4+ T cells increases Th17 cytokine signature.

Journal Article

PLoS ONE, 8 (12), pp. e81983, 2013.

Abstract | Links:

El Azreq MA, Naci D, Aoudjit F

Collagen/β1 integrin signaling up-regulates the ABCC1/MRP-1 transporter in an ERK/MAPK-dependent manner.

Journal Article

Mol Biol Cell, 23 (17), pp. 3473-84, 2012, ISSN: 1059-1524.

Abstract | Links:

Naci D, El Azreq MA, Chetoui N, Lauden L, Sigaux F, Charron D, Al-Daccak R, Aoudjit F

α2β1 integrin promotes chemoresistance against doxorubicin in cancer cells through extracellular signal-regulated kinase (ERK).

Journal Article

J Biol Chem, 287 (21), pp. 17065-76, 2012, ISSN: 0021-9258.

Abstract | Links:

Aoudjit F, Vuori K

Integrin signaling in cancer cell survival and chemoresistance.

Journal Article

Chemother Res Pract, 2012 , pp. 283181, 2012, ISSN: 2090-2107.

Abstract | Links:

52 entries « 2 of 6 »
Signaler des ajouts ou des modifications

Active projects

  • Centre de recherche du CHU de Québec - Université Laval, Subvention, Centre hospitalier universitaire de Québec - Université Laval, Centres de recherche affiliés, from 2017-01-01 to 2099-12-31
  • Expression and function of discoidin domain receptor 1 in T cells, Subvention, Conseil de recherches en sciences naturelles et génie Canada, Subventions à la découverte SD (individuelles et d'équipe), from 2017-04-01 to 2022-03-31
  • Role of discoidin domain receptor 1 in T cell migration and arthritis, Subvention, La société d'arthrite, from 2020-01-01 to 2022-12-31

Recently finished projects

  • Centre de recherche en arthrite de l'Université Laval, Subvention, Institutionnel - BDR, BDR - Entités de recherche en émergence, from 2019-01-01 to 2020-01-31
  • Elucidating the role of alpha2beta1 integrin in the chemoresistance of acute lymphoblastic leukemia., Subvention, Instituts de recherche en santé du Canada, Subvention de fonctionnement, from 2014-07-01 to 2019-06-30
  • Immunosuppressive function of S100A8 in arthritis., Subvention, Instituts de recherche en santé du Canada, Subvention de fonctionnement, from 2014-07-01 to 2019-06-30
Data provided by the Université Laval research projects registery